January 20, 2014
Meeting of Council on Unapproved Drugs and Indications with Unmet Medical Needs The Council on Unapproved Drugs and Indications with Unmet Medical Needs concluded on January 16 that public-knowledge based applications would be appropriate for Bayer Yakuhin’s levonorgestrel and Pfizer...read more